Upcoming events

Due to COVID-19 there are currently no upcoming events

News

Peripal among TOP100 Swiss Startups 2019

September 4, 2019

The Peripal Team is proud to be among 2019's Top 100 Swiss Start-ups. Peripal was highlighted at the ceremony for having received its CE mark. We say thank you to our investors for their trust and support, as well as to all the team members and partners who collaborated with us so far. And of course - we keep moving on! 

Reimbursement for PeriSafe® in Switzerland

August 20, 2019

Peripal AG receives reimbursement for its PeriSafe® System from three Swiss Health Insurance Companies - A meaningful way to bring more patients home.  

Closing of Series B Financing Round

June 27, 2019

Peripal AG closes Series B Financing Round to drive market expansion fo novel patient aid device for home dialysis. 

Peripal wins CS Top100 Investor Pitch Event

April 17, 2019

The jury at the Credit Suisse Event was most impressed with Peripal, the audience voted also for Peripal as the most impressing innovator. Sandra Neumann, CEO of Peripal, received a voucher for digital shares (value CHF 10’000) and Champagne for the celebration.  

CE mark for PeriSafe® received

March 27, 2019

The Peripal team is delighted, that after intensive development in collaboration with ETH Zurich and genuine PD patients, the PeriSafe® device for patients with peritoneal dialysis has received approval for the European market. The PeriSafe® device can be used in PD patients as of now, this can help more patients to undergo home dialysis treatments and can lower healthcare costs.  

PeriSafe® helps patients to dialyse at home

February 5, 2019

Home based dialysis, including peritoneal dialysis (PD), is associated with improved health related quality of life and reduced health resource costs. Various reasons are accountable for keeping the PD penetration as low as 10%.

 

PeriSafe®, a connection-assist device is one innovative approach to help more frail and elderly patients to start with their preferred home-based choice!

Distribution agreement with Mologic signed

May 31, 2018

As of now the novel rapid point-of-care (POC) test PERiPLEX for the detection of infection in PD patients is available at Peripal AG for Germany, Italy, The Netherlands, Austria and Switzerland. 

#vleaders China 2016: Meet Sandra Neumann

October 2, 2016

Interview with Dr. Sandra Neumann, CEO and Founder Peripal AG 

>>venture>> Awards 2016

July 1, 2016

Peripal AG placed 5th in the 2016 >>venture>> awards. 

Peripal wins de Vigier Startup Award

May 2, 2016

Peripal AG wins the 2016 WA de Vigier Startup Award.  

Sandra Neumann founds Peripal AG

June 1, 2015

Dr. Sandra Neumann founds Peripal AG in Zurich. Switzerland.  

Peripal AG

Limmatquai 112

8001 Zurich

Switzerland

info@peripal.com

Tel.: +41 44 221 95 40

© 2020 by Peripal AG